Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 0093-5005

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide (NDC 0093-5005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide active ingredient showing its molecular connectivity and arrangement.*

FDA Label Image

Olmesartan Medoxomil, Amlodipine, And Hydrochlorothiazide Tablets 40 mg/10 mg/25 mg, 90s Label (Image 10)

Label of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets, 40 mg/10 mg/25 mg strength. The label indicates this is a prescription oral film-coated tablet with a 30-tablet count, manufactured by Teva Pharmaceuticals USA, Inc. It includes the NDC number 0039-5002-56 and features dosage and safety warnings on the left side.*

FDA Label Image

Image 2

Chemical structure diagram showing molecular components of Olmesartan Medoxomil, an active ingredient in the combination tablet of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide.*

FDA Label Image

Image 3

Chemical structure diagram depicting the molecular structure of an active pharmaceutical ingredient, featuring a benzene ring with attached functional groups including NH2SO2, chlorine, and a heterocyclic sulfonamide group. This structure likely represents one of the active ingredients in the product combination Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide.*

FDA Label Image

Image 4

A line graph showing mean ambulatory diastolic blood pressure (mmHg) over 24 hours post dose. Multiple lines represent different treatment groups including baseline and various combinations of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide dosages. The x-axis represents hours post dose from 0 to 24, and the y-axis shows blood pressure measurements from 55 to 100 mmHg.*

FDA Label Image

Image 5

A line graph showing mean ambulatory systolic blood pressure (mmHg) over 24 hours post dose. The x-axis represents hours post dose (0 to 24), and the y-axis represents systolic BP (105 to 160 mmHg). Multiple lines compare baseline and various combinations of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide dosages, illustrating blood pressure changes over time.*

FDA Label Image

Image 6

Label for Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets, 20 mg/5 mg/12.5 mg strength, oral film-coated tablets. The package contains 30 tablets. Manufactured by Teva Pharmaceuticals USA, Inc. The label shows the NDC number 0093-5005-56, dosage instructions, storage conditions, and a serialization coding area.*

FDA Label Image

Image 7

The packaging label for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets by Teva Pharmaceuticals USA, Inc. The label indicates a strength of 40 mg / 5 mg / 12.5 mg in film-coated oral tablets. The pack contains 30 tablets and is marked for prescription use only. The label includes an NDC number 0093-5006-56 and a barcode for serialization.*

FDA Label Image

Image 8

Label for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets 40 mg/5 mg/25 mg, film-coated oral tablets by Teva Pharmaceuticals USA, Inc. The label indicates a package containing 30 tablets, marked Rx only, showing NDC 0093-5004-56 and includes a serialization coding area.*

FDA Label Image

Image 9

Packaging label for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets, 40 mg/10 mg/12.5 mg strength. The label indicates the product is prescription only, contains 30 film-coated tablets, and is manufactured by Teva Pharmaceuticals USA, Inc. The NDC code is 0093-5003-56.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.